ACHE and early-onset autosomal dominant Alzheimer disease: The present study sheds light on evaluating and designing novel pyrazole and benzofuran-based derivatives as potent acetylcholinesterase (AChE) inhibitors with improved antioxidant features to manage Alzheimer’s disease.